Chemokine control of HIV-1 infection.
Mellado
M
M
Rodríguez-Frade
J M
JM
Vila-Coro
A J
AJ
de Ana
A M
AM
Martínez-A
C
C
D000163:Acquired Immunodeficiency Syndrome / Q000276:immunology; D002460:Cell Line; D018932:Chemokine CCL2 / Q000378:metabolism*; D054377:Chemokine CXCL12; D019743:Chemokines, CXC / Q000378:metabolism*; D019281:Dimerization; D018450:Disease Progression; D015658:HIV Infections / Q000276:immunology*; D015497:HIV-1; D006801:Humans; D007532:Isoleucine / Q000378:metabolism; D017354:Point Mutation; D054390:Receptors, CCR2; D019713:Receptors, CCR5 / Q000235:genetics / Q000378:metabolism*; D019718:Receptors, CXCR4 / Q000235:genetics / Q000378:metabolism; D019707:Receptors, Chemokine; D018121:Receptors, Cytokine / Q000235:genetics / Q000378:metabolism*; D014633:Valine / Q000378:metabolism
C515334:CCR2 protein, human; C515255:CXCL12 protein, human; D018932:Chemokine CCL2; D054377:Chemokine CXCL12; D019743:Chemokines, CXC; D054390:Receptors, CCR2; D019713:Receptors, CCR5; D019718:Receptors, CXCR4; D019707:Receptors, Chemokine; D018121:Receptors, Cytokine; D007532:Isoleucine; D014633:Valine